An Open-label, single-arm clinical trial to evaluate Efficacy and Safety of Hariras Ayurvedic pills for symptomatic relief of acute nonproductive Cough and Throat Irritation - NI

Sushrutkrupa Ayurvedic Pharmacy Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1. Male and female subjects (18 to 65 years of age) with history of acute nonproductive cough and throat irritation for less than 1week duration
•2. Subjects with a cough score of 0, 1, or 2 during daytime
•3. Subjects willing and able to provide signed informed consent forms before any study-related procedures.
•4. Subjects willing to abstain from other medication (allopathic or herbal) for cough treatment during the study period
•5. Subjects who in the opinion of the Investigator will be able to comply with the study requirements

•1. Subjects with a history of lower respiratory tract infections such as Pneumonia, Tuberculosis, Bronchitis, and Whooping cough.
•2. Subjects with a history of Chronic Obstructive Pulmonary Diseases, Asthma
•3. Subjects with a history of underlying lung pathology such as lung abscess, or cystic fibrosis.
•4. Subjects with known hypersensitivity to any ingredients of the investigational products
•5. Subjects with clinical suspicion of any systemic bacterial infection.
•6. Subjects with a history of Myocardial Infarction (MI) within 4 weeks before enrollment
•7. Subjects with immediate life-threatening diseases such as pre-existing cardiovascular, liver or neoplastic disease.
•8. Subjects who had received any sedative, hypnotic or tranquilizer within 14 days before randomization
•9. Subjects who had received any of the anti-histamines, cough suppressants, mucolytics, expectorants, or antibiotics within 3 days before randomization.

发起方

Sushrutkrupa Ayurvedic Pharmacy Pvt. Ltd.